MX2024008162A - Formulaciones parenterales estimulantes respiratorias. - Google Patents
Formulaciones parenterales estimulantes respiratorias.Info
- Publication number
- MX2024008162A MX2024008162A MX2024008162A MX2024008162A MX2024008162A MX 2024008162 A MX2024008162 A MX 2024008162A MX 2024008162 A MX2024008162 A MX 2024008162A MX 2024008162 A MX2024008162 A MX 2024008162A MX 2024008162 A MX2024008162 A MX 2024008162A
- Authority
- MX
- Mexico
- Prior art keywords
- parenteral formulations
- respiratory stimulant
- compound
- disclosed
- stimulant
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163293985P | 2021-12-27 | 2021-12-27 | |
| US202263313472P | 2022-02-24 | 2022-02-24 | |
| PCT/US2022/053935 WO2023129502A1 (en) | 2021-12-27 | 2022-12-23 | Respiratory stimulant parenteral formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2024008162A true MX2024008162A (es) | 2024-09-17 |
Family
ID=86992921
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2024008162A MX2024008162A (es) | 2021-12-27 | 2022-12-23 | Formulaciones parenterales estimulantes respiratorias. |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20230210857A1 (enExample) |
| EP (1) | EP4456900A4 (enExample) |
| JP (1) | JP2025501169A (enExample) |
| KR (1) | KR20240150426A (enExample) |
| AU (1) | AU2022426492A1 (enExample) |
| CA (1) | CA3242509A1 (enExample) |
| MX (1) | MX2024008162A (enExample) |
| TW (1) | TW202333732A (enExample) |
| WO (1) | WO2023129502A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4543455A4 (en) * | 2022-06-24 | 2026-06-03 | Enalare Therapeutics Inc | METHODS OF TREATMENT FOR NEUROLOGICAL VENTILATORY FAILURE |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE69729880T3 (de) * | 1996-12-24 | 2012-05-10 | Biogen Idec Ma Inc. | Stabile flüssige interferon-zubereitungen |
| SG10201601507YA (en) * | 2010-11-29 | 2016-04-28 | Galleon Pharmaceuticals Inc | Novel compounds as respiratory stimulants for treatment of breathing control disorders or diseases |
| US20120295911A1 (en) * | 2010-11-29 | 2012-11-22 | Galleon Pharmaceuticals, Inc. | Novel Compounds and Compositions for Treatment of Breathing Control Disorders or Diseases |
| AU2012250050B2 (en) * | 2011-04-28 | 2017-04-06 | Platform Brightworks Two, Ltd. | Improved parenteral formulations of lipophilic pharmaceutical agents and methods for preparing and using the same |
| BR112015011213A2 (pt) * | 2012-11-15 | 2017-08-29 | Galleon Pharmaceuticals Inc | Composto, composição farmacêutica, método de prevenção ou tratamento de um distúrbio ou doença de controle respiratório em um indivíduo, método de prevenção de desestabilização ou de estabilização do ritmo respiratório em um indivíduo, método de preparação de o,n-dimetil-n-[4-(n-propilamina)-6-(prop-2-inilamina)-[1,3,5]triazin-2-il]-hidroxilamina, e composição. |
| GB201502412D0 (en) * | 2015-02-13 | 2015-04-01 | Canbex Therapeutics Ltd | Therapeutic use |
-
2022
- 2022-12-23 JP JP2024539090A patent/JP2025501169A/ja active Pending
- 2022-12-23 WO PCT/US2022/053935 patent/WO2023129502A1/en not_active Ceased
- 2022-12-23 AU AU2022426492A patent/AU2022426492A1/en active Pending
- 2022-12-23 EP EP22917259.8A patent/EP4456900A4/en active Pending
- 2022-12-23 MX MX2024008162A patent/MX2024008162A/es unknown
- 2022-12-23 KR KR1020247025381A patent/KR20240150426A/ko active Pending
- 2022-12-23 US US18/088,137 patent/US20230210857A1/en active Pending
- 2022-12-23 CA CA3242509A patent/CA3242509A1/en active Pending
- 2022-12-27 TW TW111150221A patent/TW202333732A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP4456900A1 (en) | 2024-11-06 |
| TW202333732A (zh) | 2023-09-01 |
| WO2023129502A1 (en) | 2023-07-06 |
| KR20240150426A (ko) | 2024-10-15 |
| US20230210857A1 (en) | 2023-07-06 |
| JP2025501169A (ja) | 2025-01-17 |
| EP4456900A4 (en) | 2025-12-24 |
| CA3242509A1 (en) | 2023-07-06 |
| AU2022426492A1 (en) | 2024-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2022125616A8 (en) | Dialkyl tryptamines and their therapeutic uses | |
| MX2023014620A (es) | Nuevos profarmacos y conjugados de dimetiltriptamina. | |
| MX2021003739A (es) | Derivados de quinolino-pirrolidin-2-ona como inhibidores del gen mutado de ataxia telangiectasia (atm) y el uso de los mismos en el tratamiento de tumores sólidos. | |
| AU2021323253A8 (en) | Heterocyclic GLP-1 agonists | |
| WO2023192602A3 (en) | Respiratory stimulant nasal formulations | |
| NZ600231A (en) | Pharmaceutical compositions comprising sigma receptor ligands | |
| SG10201407538WA (en) | Intravenous formulations of neurokinin-1 antagonists | |
| MX2022004450A (es) | Aminas de heteroaril-bifenilo para el tratamiento de enfermedades pd-l1. | |
| MX2024014628A (es) | Compuesto para inhibir o degradar bcl6 y uso de este en farmacia | |
| NO20051389L (no) | Stabilisert farmasoytisk blanding inneholdende basiske hjelpemidler | |
| BRPI0516453A (pt) | derivados de benzoimidazol úteis como agentes antiproliferativos | |
| MX2024009177A (es) | Compuestos y metodos de uso | |
| SG165162A1 (en) | Modified release pharmaceutical formulation | |
| WO2023129956A3 (en) | Dimethyltryptamine analogues as nitric oxide delivery drugs | |
| PH12023552774A1 (en) | Nek7 inhibitors | |
| MX2025007492A (es) | Compuestos lipidicos y composiciones de nanoparticulas lipidicas | |
| CA3242509A1 (en) | Respiratory stimulant parenteral formulations | |
| PL432858A1 (pl) | Związki stanowiące C20-modyfikowane pochodne salinomycyny, sposób ich otrzymywania, kompozycja je zawierająca, zastosowanie tych związków oraz sposób otrzymywania produktu pośredniego | |
| MY200061A (en) | Irak inhibitor and preparation method therefor and use thereof | |
| MX2023009052A (es) | Compuesto de bifenilo como inmunomodulador, método de preparación para el mismo y uso del mismo. | |
| MX2023013225A (es) | Inhibidores de la cinasa 4 similar a polo. | |
| GEAP202516737A (en) | Compounds for treating cancer | |
| MX2025002355A (es) | Compuestos de triazina y usos de los mismos | |
| SE0201658D0 (sv) | Immediate release pharmaceutical formulation | |
| CO2022008616A2 (es) | Composición farmacéutica oral que comprende compuesto de carbamato y método de preparación para la misma |